Literature DB >> 29128268

Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency.

Abdulmaged M Traish1.   

Abstract

INTRODUCTION: Testosterone (T) deficiency (TD; hypogonadism) has deleterious effects on men's health; negatively affects glycometabolic and cardiometabolic functions, body composition, and bone mineral density; contributes to anemia and sexual dysfunction; and lowers quality of life. T therapy (TTh) has been used for the past 8 decades to treat TD, with positive effects on signs and symptoms of TD. AIM: To summarize the health benefits of TTh in men with TD.
METHODS: A comprehensive literature search was carried out using PubMed, articles relevant to TTh were accessed and evaluated, and a comprehensive summary was synthesized. MAIN OUTCOME MEASURES: Improvements in signs and symptoms of TD reported in observational studies, registries, clinical trials, and meta-analyses were reviewed and summarized.
RESULTS: A large body of evidence provides significant valuable information pertaining to the therapeutic value of TTh in men with TD. TTh in men with TD provides real health benefits for bone mineral density, anemia, sexual function, glycometabolic and cardiometabolic function, and improvements in body composition, anthropometric parameters, and quality of life.
CONCLUSION: TTh in the physiologic range for men with TD is a safe and effective therapeutic modality and imparts great benefits on men's health and quality of life. Traish AM. Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency. Sex Med Rev 2018;6:86-105.
Copyright © 2017 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone Mineral Density; Diabetes; Metabolic Syndrome; Sexual Function; Testosterone; Testosterone Deficiency; Testosterone Therapy

Mesh:

Substances:

Year:  2017        PMID: 29128268     DOI: 10.1016/j.sxmr.2017.10.001

Source DB:  PubMed          Journal:  Sex Med Rev        ISSN: 2050-0521


  11 in total

1.  Testosterone Recovery Profiles After Cessation of Androgen Deprivation Therapy for Prostate Cancer.

Authors:  Bruno Nascimento; Eduardo P Miranda; Lawrence C Jenkins; Nicole Benfante; Elizabeth A Schofield; John P Mulhall
Journal:  J Sex Med       Date:  2019-05-09       Impact factor: 3.802

Review 2.  Lifestyle modifications and pharmacological approaches to improve sexual function and satisfaction in men with spinal cord injury: a narrative review.

Authors:  Chloe A R Lim; Tom E Nightingale; Stacy Elliott; Andrei V Krassioukov
Journal:  Spinal Cord       Date:  2019-12-19       Impact factor: 2.772

Review 3.  Pathophysiological effects of androgens on the female vascular system.

Authors:  Tori Stone; Nina S Stachenfeld
Journal:  Biol Sex Differ       Date:  2020-07-29       Impact factor: 5.027

4.  Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study.

Authors:  Karim Sultan Haider; Ahmad Haider; Farid Saad; Gheorghe Doros; Markolf Hanefeld; Sandeep Dhindsa; Paresh Dandona; Abdulmaged Traish
Journal:  Diabetes Obes Metab       Date:  2020-07-15       Impact factor: 6.577

5.  Barriers to receiving testosterone replacement therapy in the community during COVID-19 pandemic.

Authors:  Victoria L Troesch; Denise Juhr; Amy Pearlman
Journal:  Transl Androl Urol       Date:  2021-08

6.  A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism.

Authors:  Anthony DelConte; Kongnara Papangkorn; Kilyoung Kim; Benjamin J Bruno; Nachiappan Chidambaram; Mohit Khera; Irwin Goldstein; Tobias S Kohler; Martin Miner; Adrian S Dobs; Mahesh V Patel
Journal:  Andrology       Date:  2022-01-18       Impact factor: 4.456

7.  Baseline Gonadotropin Levels and Testosterone Response in Hypogonadal Men Treated With Clomiphene Citrate.

Authors:  Sorena Keihani; Lindsey N Wright; Nathan J Alder; Jinfeng Jiang; Philip J Cheng; Gregory J Stoddard; Alexander W Pastuszak; Christopher M Deibert; James M Hotaling
Journal:  Urology       Date:  2020-04-28       Impact factor: 2.649

Review 8.  The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts.

Authors:  Omer Faruk Kirlangic; Didem Yilmaz-Oral; Ecem Kaya-Sezginer; Gamze Toktanis; Aybuke Suveyda Tezgelen; Ekrem Sen; Armagan Khanam; Cetin Volkan Oztekin; Serap Gur
Journal:  Sex Med       Date:  2020-03-20       Impact factor: 2.491

9.  The Testosterone Effect on Metabolic and Urologic Outcomes in Patients with Nonfunctioning Pituitary Macroadenomas and Hypogonadotropic Hypogonadism.

Authors:  Guadalupe Vargas-Ortega; Gabriel Pérez-Villarreal; Andrés Ramírez de Santiago; Lourdes Balcázar-Hernández; Victoria Mendoza-Zubieta; Oscar Landa-Gutierrez; Carlos Estrada-Robles; Baldomero González-Virla
Journal:  Int J Endocrinol       Date:  2019-11-03       Impact factor: 3.257

10.  Case Report: Low Bone and Normal Lean Mass in Adolescents With Complete Androgen Insensitivity Syndrome.

Authors:  Aaron Misakian; Michelle McLoughlin; Louisa C Pyle; Thomas F Kolon; Andrea Kelly; Maria G Vogiatzi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-30       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.